Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ LMO7 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA518229
Description
This antibody is predicted to react with canine, mouse and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 32,000.
The LIM-only (LMO) proteins are nuclear factors characterized by a conserved LIM domain. The LIM domain contains a cysteine-rich zinc-binding motif, present in a variety of transcription factors, including the LIM homeobox (LHX) proteins expressed in the central nervous system. The deduced LMO7 protein is comprised of 1,349 amino acid residues, contains a characteristic zinc finger domain and a 3-prime UTR which possesses a short interspersed nucleotide element (SINE). RT-PCR detects predominant expression of LMO7 in heart, lung, skeletal muscle, and kidney, moderate expression in liver, ovary, brain, pancreas, and testis, and little to no expression in spleen. Research indicates that LMO7 is an afadin- and alpha-actinin-binding protein that connects the nectin-afadin and E-cadherin-catenin systems through alpha-actinin.
Specifications
LMO7 | |
Polyclonal | |
Unconjugated | |
LMO7 | |
C78582; F-box only protein 20; F-box protein Fbx20; FBX20; FBXO20; Gm914; KIAA0858; LIM domain 7; LIM domain only 7; LIM domain only 7 protein; LIM domain only protein 7; LMO7; LMO-7; LOMP; LOMP protein; mKIAA0858; RP11-332E3.2; TGF-beta induced protein; zinc-finger domain-containing protein | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
4008 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
Q8WWI1 | |
LMO7 | |
Synthetic peptide sequence (ESTCVSASLPRS) corresponding to the internal amino acids of LMO7 (aa 895-900). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction